Occult hepatitis C virus infection in patients with beta-thalassemia major: Is it a neglected and unexplained phenomenon?

ABO blood groups beta-thalassemia major occult hepatitis C virus infection serum uric acid

Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 23 10 2018
accepted: 17 12 2018
pubmed: 19 2 2019
medline: 19 2 2019
entrez: 19 2 2019
Statut: ppublish

Résumé

Occult hepatitis C virus (HCV) infection (OCI) is described as the presence of viral genome in both hepatocytes and peripheral blood mononuclear cells (PBMCs) despite constant negative results on serum HCV RNA tests. Beta-thalassemia major (BTM) describes a group of inherited blood diseases. Patients with BTM require repeated blood transfusions, increasing the risk of exposure to infectious agents. We aimed to assess the prevalence of OCI in Iranian BTM patients and to identify the role of host factors in OCI positivity. A total of 181 BTM patients with HCV negative markers were selected. HCV RNA was tested in PBMCs using nested polymerase chain reaction assay. The positive samples were then genotyped via restriction fragment-length polymorphism (RFLP) and 5'-untranslated region sequencing. Six (3.3%) out of 181 BTM patients had viral HCV genomes in PBMC samples. Three (50.0%), two (33.3%), and one (16.7%) out of these six patients were infected with HCV-1b, HCV-1a, and HCV-3a, respectively. OCI positivity was significantly associated with the serum level of uric acid (P = 0.045) and ABO blood group (P = 0.032). Also, OCI patients had unfavorable IFNL3 rs12979860 TT, IFNL3 rs8099917 GG, IFNL3 rs12980275 GG, and IFNL4 ss469415590 ∆G/∆G genotypes. In conclusion, we indicated the low frequency of OCI in BTM patients. Nevertheless, more attention is warranted considering the importance of this infection. Also, further studies are necessary to determine the actual prevalence of OCI among BTM patients in Iran.

Identifiants

pubmed: 30775813
doi: 10.1002/jcb.28472
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11908-11914

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Ahmad Ayadi (A)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Amir Hossein Nafari (AH)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Shiva Irani (S)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Elham Mohebbi (E)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Fahimeh Mohebbi (F)

Department of Network Science and Technology, University of Tehran, Tehran, Iran.

Fatemeh Sakhaee (F)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.

Farzam Vaziri (F)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Seyed Davar Siadat (SD)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Abolfazl Fateh (A)

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran.

Classifications MeSH